{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:33:34Z","timestamp":1787009614876,"version":"build-2736575974"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe the effectiveness and safety of biologics for the treatment of relapsing and\/or refractory polyarteritis nodosa (PAN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective European collaborative study was conducted in patients with PAN who received biologics for relapsing and\/or refractory disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-two patients with PAN received a total of 53 biologic courses, including TNF-\u03b1 blockers in 15 cases, rituximab (RTX) in 18 cases, tocilizumab (TCZ) in 10 cases and other biologics in 10 cases. TNF-\u03b1 blockers and TCZ were mainly used for refractory diseases whereas RTX was mainly initiated for relapsing disease. After a median follow-up of 29 (8\u201350) months, remission, partial response, treatment failure and treatment discontinuation due to severe adverse events occurred in, respectively, 40%, 13%, 40% and 7% of patients receiving TNF-\u03b1 blockers, 50%, none, 30% and 20% of TCZ recipients, and 33%, 11%, 56% and none of the RTX recipients. No remission was noted in patients treated with other biologics. Severe adverse events were observed in 14 (28%) patients without significant differences between the three biologics, leading to early biologics discontinuation in only three cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These results suggest that TCZ may be effective in relapsing and\/or refractory PAN. Our data warrant further study to confirm these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac332","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T09:05:15Z","timestamp":1654851915000},"page":"341-346","source":"Crossref","is-referenced-by-count":18,"title":["Use of biologics to treat relapsing and\/or refractory polyarteritis nodosa: data from a European collaborative study"],"prefix":"10.1093","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-3272","authenticated-orcid":false,"given":"J\u00e9rome","family":"Hadjadj","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, APHP-CUP, H\u00f4pital Cochin , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Canzian","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, APHP-CUP, H\u00f4pital Cochin , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-3117","authenticated-orcid":false,"given":"Omer","family":"Karadag","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Vasculitis Research Centre, Hacettepe University , Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Contis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Saint Andre Hospital, University Hospital Centre of Bordeaux , Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Maurier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Immunology, Groupe Hospitalier UNEOS , Metz-Vantoux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Sanges","sequence":"additional","affiliation":[{"name":"Univ. Lille, Inserm, CHU Lille, Service de M\u00e9decine Interne et Immunologie Clinique, Centre de r\u00e9f\u00e9rence des maladies autoimmunes syst\u00e9miques rares du Nord et Nord-Ouest de France (CeRAINO), U1286 \u2013 INFINITE\u2014Institute for Translational Research in Inflammation , Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8842-6214","authenticated-orcid":false,"given":"Silvia","family":"Sartorelli","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Denis","sequence":"additional","affiliation":[{"name":"CHU de Estaing , Clermont-Ferrand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"de Moreuil","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, CHU , Brest"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile-Audrey","family":"Durel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Edouard Herriot, Hospices Civils de Lyon , Lyon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Durupt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Edouard Herriot, Hospices Civils de Lyon , Lyon"},{"name":"Service de M\u00e9decine Interne, Centre Hospitalier Universitaire Lyon Sud, Hospices Civils de Lyon , Pierre-B\u00e9nite"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Jachiet","sequence":"additional","affiliation":[{"name":"Department of Dermatology, H\u00f4pital-Saint-Louis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Rouzaud","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine Interne, H\u00f4pital Bichat, Universit\u00e9 de Paris, Assistance Publique H\u00f4pitaux de Paris , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Dipartimento Medicina Interna e Specialit\u00e0 Mediche, Azienda Unit\u00e0 Sanitaria Locale di Reggio Emilia-Istituto di Ricerca e Cura a Carattere Scientifico , Reggio Emilia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2356-375X","authenticated-orcid":false,"given":"Roberto","family":"Padoan","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine DIMED, University of Padova , Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Bonnet","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Infectious Diseases, Bordeaux University Hospital, Saint Andr\u00e9 Hospital , Bordeaux"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1156-0607","authenticated-orcid":false,"given":"Christian","family":"Agard","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Nantes Universit\u00e9, CHU Nantes , Nantes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4134-6086","authenticated-orcid":false,"given":"Thomas","family":"Moulinet","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Immunology, Center de Comp\u00e9tence des Maladies Autoimmunes Syst\u00e9miques Rares, CHU Nancy, University of Lorraine, Vandoeuvre-l\u00e8s-Nancy, France; UMR 7365, IMoPA, University of Lorraine, CNRS , Nancy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Hermet","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre Hospitalier , Vichy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raluca","family":"Sterpu","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Immunologie Clinique, M\u00e9decine Aig\u00fce Polyvalente, H\u00f4pital Antoine-B\u00e9cl\u00e8re-AP-HP , Clamart"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre Thibault Jacques","family":"Maria","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Multiorgan Diseases, Referral Center for Auto-immune Diseases, Saint-Eloi Hospital Montpellier University , Montpellier"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Keraen","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre Hospitalier Cornouaille , Quimper, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Guillevin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, APHP-CUP, H\u00f4pital Cochin , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jayne","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Centre Hospitalier Cornouaille , Quimper, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP, APHP-CUP, H\u00f4pital Cochin , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"2022122410111990300_keac332-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2022122410111990300_keac332-B2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.autrev.2016.02.015","article-title":"Polyarteritis nodosa: a contemporary overview","volume":"15","author":"De Virgilio","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2022122410111990300_keac332-B3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"2022122410111990300_keac332-B4","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/art.40205","article-title":"Adding azathioprine to remission-induction glucocorticoids for eosinophilic granulomatosis with polyangiitis (Churg-Strauss), microscopic polyangiitis, or polyarteritis nodosa without poor prognosis factors: a randomized, controlled trial","volume":"69","author":"Pu\u00e9chal","year":"2017","journal-title":"Arthritis Rheumatol (Hoboken)"},{"key":"2022122410111990300_keac332-B5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2340\/00015555-1228","article-title":"Serum levels of interleukin-6 in patients with cutaneous polyarteritis nodosa","volume":"92","author":"Kawakami","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"2022122410111990300_keac332-B6","article-title":"Tocilizumab for the treatment of polyarteritis nodosa: a systematic literature review","author":"Akiyama","journal-title":"Ann Rheum Dis"},{"key":"2022122410111990300_keac332-B7","doi-asserted-by":"crossref","first-page":"e11053","DOI":"10.1097\/MD.0000000000011053","article-title":"Adalimumab therapy in hepatitis B virus-negative polyarteritis nodosa: a case report","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2022122410111990300_keac332-B8","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1007\/s10067-019-04474-9","article-title":"Infliximab for the treatment of refractory polyarteritis nodosa","volume":"38","author":"Ginsberg","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2022122410111990300_keac332-B9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s13023-020-01621-3","article-title":"French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)","volume":"15","author":"Terrier","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"2022122410111990300_keac332-B10","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 103","key":"2022122410111990300_keac332-B11","first-page":"176","article-title":"Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial","volume":"35","author":"Samson","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2022122410111990300_keac332-B12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/acr.24633","article-title":"2021 American College of Rheumatology\/vasculitis foundation guideline for the management of polyarteritis nodosa","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Care Res"},{"key":"2022122410111990300_keac332-B13","doi-asserted-by":"crossref","first-page":"102784","DOI":"10.1016\/j.autrev.2021.102784","article-title":"Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: a narrative review","volume":"20","author":"Conticini","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2022122410111990300_keac332-B14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/ped.14184","article-title":"Successful treatment of tumor necrosis factor inhibitor-resistant cutaneous polyarteritis nodosa with tocilizumab","volume":"62","author":"Inoue","year":"2020","journal-title":"Pediatr Int"},{"key":"2022122410111990300_keac332-B15","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJMc1801927","article-title":"Treatment strategies for deficiency of adenosine deaminase 2","volume":"380","author":"Ombrello","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac332\/44110285\/keac332.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/1\/341\/48407147\/keac332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/1\/341\/48407147\/keac332.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T05:11:40Z","timestamp":1671858700000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/1\/341\/6605213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,6,10]]},"published-print":{"date-parts":[[2022,12,23]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac332","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,6,10]]}}}